NVZMF - Novonesis A/S (NVZMF) Q1 2025 Earnings Call Transcript
2025-05-11 10:32:06 ET
Novonesis A/S (NVZMF)
Q1 2025 Earnings Conference Call
May 08, 2025, 03:00 AM ET
Company Participants
Tobias Björklund - Head, Investor Relations
Ester Baiget - Chief Executive Officer
Rainer Lehmann - Chief Financial Officer
Amy Byrick - Executive Vice President, Human Health Biosolutions
Tina Fano - Executive Vice President, Planetary Health Biosolutions
Claus Crone Fuglsang - Chief Scientific Officer
Conference Call Participants
Alex Sloane - Barclays
Matthew Yates - Bank of America
Thomas Lind Petersen - Nordea
Charles Eden - UBS
Ranulf Orr - Citibank
Søren Samsøe - SEB
Nicola Tang - BNP Paribas
Chetan Udeshi - JP. Morgan
André Thormann - Danske Bank
Presentation
Operator
Tobias Björklund
Thank you very much, operator, and welcome, everyone, to the Novonesis Conference Call for the First Quarter of 2025. My name is Tobias Björklund, and as said, I'm heading up our Investor Relation activities here at Novonesis.
In this call, our CEO, Ester Baiget, and our CFO, Rainer Lehmann, will review our performance for the year, as well as the outlook for 2025. Also that are attending today's calls are Amy Byrick, EVP of Human Health Biosolutions, Tina Fano, EVP of Planetary Health Biosolutions, and Claus Fuglsang, Chief Scientific Officer. The conference call will take about 45 minutes, including Q&A. Please change to the next slide....
Novonesis A/S (NVZMF) Q1 2025 Earnings Call Transcript